Malcolm is a pediatric resident from Münster, Germany, who decided to take a break from clinical work to pursue his dream of becoming a successful clinician scientist. He is fascinated by the improvement that CAR T cell therapy has already brought to his patients and is now eager to enhance it even further. During his MD thesis he learned a lot about cell death signaling and therefore tries to combine these topics to strengthen CAR efficacy against solid pediatric cancers.